Orgenesis Inc. Inventory

Inventory of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Inventory growth rates and interactive chart. Inventory is the term for the goods available for sale and raw materials used to produce goods available for sale. Inventory represents one of the most important assets of a business because the turnover of inventory represents one of the primary sources of revenue generation and subsequent earnings for the company's shareholders.

Highlights and Quick Summary

  • Inventory for the quarter ending September 29, 2021 was $133 Thousand (a -23.12% decrease compared to previous quarter)
  • Year-over-year quarterly Inventory decreased by -28.11%
  • Annual Inventory for 2020 was $185 Thousand (a 36.03% increase from previous year)
  • Annual Inventory for 2019 was $136 Thousand (a -92.17% decrease from previous year)
  • Annual Inventory for 2018 was $1.74 Million (a 0.0% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Inventory of Orgenesis Inc.

Most recent Inventoryof ORGS including historical data for past 10 years.

Interactive Chart of Inventory of Orgenesis Inc.

Orgenesis Inc. Inventory for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $0.13 $0.17 $0.2
2020 $0.19 $0.15 $0.18 $0.13 $0.19
2019 $0.14 $1.86 $2.22 $1.99 $0.14
2018 $1.74 $1.66 $1.23 $0.88 $1.74
2017 $0.73 $0.97 $0.9 $0.73
2016 $0.4 $0.4 $0.4 $0.4
2015 $0.3 $0.3

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.